Comparison of Intravitreal Injection of Ranibizumab Versus Sham Injection Before Vitrectomy in Patients With Proliferative Diabetic Retinopathy: a Single-center, Prospective Double-blinded Randomized Controlled Trial
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 04 Aug 2017
At a glance
- Drugs Ranibizumab (Primary)
- Indications Perioperative haemorrhage
- Focus Therapeutic Use
- 01 Aug 2017 Planned End Date changed from 1 Jan 2017 to 1 Sep 2017.
- 01 Aug 2017 Planned primary completion date changed from 1 Jan 2017 to 1 Sep 2017.
- 01 Aug 2017 Status changed from recruiting to active, no longer recruiting.